Annual EBITDA
$181.19 M
+$53.62 M+42.03%
December 31, 2023
Summary
- As of February 10, 2025, SWAV annual EBITDA is $181.19 million, with the most recent change of +$53.62 million (+42.03%) on December 31, 2023.
- During the last 3 years, SWAV annual EBITDA has risen by +$243.73 million (+389.69%).
Performance
SWAV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
$56.05 M
-$5.43 M-8.84%
March 31, 2024
Summary
- As of February 10, 2025, SWAV quarterly EBITDA is $56.05 million, with the most recent change of -$5.43 million (-8.84%) on March 31, 2024.
- Over the past year, SWAV quarterly EBITDA has dropped by -$5.43 million (-8.84%).
Performance
SWAV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
$204.51 M
+$12.97 M+6.77%
March 31, 2024
Summary
- As of February 10, 2025, SWAV TTM EBITDA is $204.51 million, with the most recent change of +$12.97 million (+6.77%) on March 31, 2024.
- Over the past year, SWAV TTM EBITDA has increased by +$12.97 million (+6.77%).
Performance
SWAV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SWAV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.0% | -8.8% | +6.8% |
| 3 y3 years | +389.7% | -8.8% | +6.8% |
| 5 y5 years | +553.4% | -8.8% | +6.8% |
SWAV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -102.3% | -8.8% | -74.6% | at high | -102.0% |
| 5 y | 5-year | at high | -134.5% | -8.8% | -139.5% | at high | -132.5% |
| alltime | all time | at high | -134.5% | -8.8% | -139.5% | at high | -132.5% |
ShockWave Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $56.05 M(-8.8%) | $204.51 M(+6.8%) |
| Dec 2023 | $181.19 M(+42.0%) | $61.48 M(+21.5%) | $191.54 M(+8.1%) |
| Sep 2023 | - | $50.60 M(+39.1%) | $177.22 M(+8.5%) |
| Jun 2023 | - | $36.38 M(-15.6%) | $163.32 M(+5.6%) |
| Mar 2023 | - | $43.08 M(-8.7%) | $154.68 M(+21.3%) |
| Dec 2022 | $127.57 M(-3166.6%) | $47.16 M(+28.5%) | $127.57 M(+34.8%) |
| Sep 2022 | - | $36.70 M(+32.3%) | $94.65 M(+54.6%) |
| Jun 2022 | - | $27.75 M(+73.8%) | $61.24 M(+80.5%) |
| Mar 2022 | - | $15.97 M(+12.1%) | $33.93 M(-915.6%) |
| Dec 2021 | -$4.16 M(-93.3%) | $14.24 M(+334.4%) | -$4.16 M(-87.7%) |
| Sep 2021 | - | $3.28 M(+650.3%) | -$33.95 M(-30.7%) |
| Jun 2021 | - | $437.00 K(-102.0%) | -$48.97 M(-26.2%) |
| Mar 2021 | - | -$22.12 M(+42.2%) | -$66.38 M(+7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$62.54 M(+30.8%) | -$15.55 M(+32.5%) | -$61.94 M(+2.8%) |
| Sep 2020 | - | -$11.73 M(-30.9%) | -$60.24 M(-0.6%) |
| Jun 2020 | - | -$16.98 M(-4.0%) | -$60.60 M(+13.4%) |
| Mar 2020 | - | -$17.68 M(+27.7%) | -$53.46 M(+11.8%) |
| Dec 2019 | -$47.82 M(+19.7%) | -$13.85 M(+14.5%) | -$47.82 M(+6.8%) |
| Sep 2019 | - | -$12.10 M(+23.1%) | -$44.77 M(+5.3%) |
| Jun 2019 | - | -$9.83 M(-18.4%) | -$42.50 M(-0.1%) |
| Mar 2019 | - | -$12.04 M(+11.6%) | -$42.56 M(+6.5%) |
| Dec 2018 | -$39.96 M(+32.9%) | -$10.79 M(+9.8%) | -$39.96 M(+37.0%) |
| Sep 2018 | - | -$9.83 M(-0.6%) | -$29.17 M(+50.8%) |
| Jun 2018 | - | -$9.89 M(+4.7%) | -$19.34 M(+104.7%) |
| Mar 2018 | - | -$9.45 M | -$9.45 M |
| Dec 2017 | -$30.06 M | - | - |
FAQ
- What is ShockWave Medical annual EBITDA?
- What is the all time high annual EBITDA for ShockWave Medical?
- What is ShockWave Medical annual EBITDA year-on-year change?
- What is ShockWave Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for ShockWave Medical?
- What is ShockWave Medical quarterly EBITDA year-on-year change?
- What is ShockWave Medical TTM EBITDA?
- What is the all time high TTM EBITDA for ShockWave Medical?
- What is ShockWave Medical TTM EBITDA year-on-year change?
What is ShockWave Medical annual EBITDA?
The current annual EBITDA of SWAV is $181.19 M
What is the all time high annual EBITDA for ShockWave Medical?
ShockWave Medical all-time high annual EBITDA is $181.19 M
What is ShockWave Medical annual EBITDA year-on-year change?
Over the past year, SWAV annual EBITDA has changed by +$53.62 M (+42.03%)
What is ShockWave Medical quarterly EBITDA?
The current quarterly EBITDA of SWAV is $56.05 M
What is the all time high quarterly EBITDA for ShockWave Medical?
ShockWave Medical all-time high quarterly EBITDA is $61.48 M
What is ShockWave Medical quarterly EBITDA year-on-year change?
Over the past year, SWAV quarterly EBITDA has changed by -$5.43 M (-8.84%)
What is ShockWave Medical TTM EBITDA?
The current TTM EBITDA of SWAV is $204.51 M
What is the all time high TTM EBITDA for ShockWave Medical?
ShockWave Medical all-time high TTM EBITDA is $204.51 M
What is ShockWave Medical TTM EBITDA year-on-year change?
Over the past year, SWAV TTM EBITDA has changed by +$12.97 M (+6.77%)